CN¥ 10.75
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical company, develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia areas in China and internationally. It offers APIs, intermediates, FDF, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company was founded in 1997 and is headquartered in Zhuhai, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA, overpriced on P
Data is available to registered users only